(Q35958231)

English

A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

0 references

A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Christian Torp-Pedersen

5

object named as

Christian Torp-Pedersen

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

4

object named as

Lars Kober

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Steen Z. Abildstrom

2

object named as

Steen Z Abildstrom

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1

object named as

Jawdat Abdulla

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

author name string

Erik Christensen

3

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

927-935

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Multicenter, randomized, placebo-controlled, double-blind study of the safety and efficacy of oral delapril in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Captopril in heart failure. A double blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Controlled trial of enalapril in congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Effects of enalapril on myocardial noradrenaline overflow during exercise in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Left ventricular filling dynamics by Doppler echocardiography in dilated cardiomyopathy: one-year follow-up in patients treated with captopril compared to placebo

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Enalapril in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Converting enzyme inhibition and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Comparative effects of long-term therapy with captopril and ibopamine in chronic congestive heart failure in old patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Meta-analysis of morbidity and mortality in five exercise capacity trials evaluating ramipril in chronic congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.02.002

21 January 2018

Identifiers

10.1016/J.EJHEART.2004.02.002

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35958231&oldid=1981169820"